Untitled

Loading Events

« All Webinars

“DDI Webinar Series: Ongoing Role of FDA in Medication Error Prevention”

U.S. Food & Drug Administration (FDA) presents…

“DDI Webinar Series: Ongoing Role of FDA in Medication Error Prevention”

This series of educational webinars is designed to aid physicians, physician assistants, nurses, pharmacists, pharmacy technicians, students, and other health care professionals, to provide better patient care by knowing how to find relevant FDA regulatory information that will improve drug safety. This webinar will provide information on the Division of Medication Error Prevention and Analysis (DMEPA)’s role in preventing and addressing medication errors. Regulatory action taken to address recent medication error reports will be explored, as well as the role of pharmacists in identifying, preventing and mitigating medication errors.

Learning Objectives:

  1. Explain how to utilize FDA’s drug information, medication safety resources, and regulatory guidance, to improve delivery of patient care and optimize outcomes.
  2. Describe and inform health care providers of recent labeling changes which would impact prescribing and medication management to optimize patient care.
  3. Describe the Division of Medication Error Prevention and Analysis’ role in pre-marketing and post-marketing activities to prevent and address medication errors.
  4. Provide a brief overview of strategies aimed to increase the safe use of drug products by minimizing use error that is related to the design, naming, labeling, and/or packaging of drug products.
  5. Provide examples of regulatory action taken to address recent medication errors.
  6. Describe how you can help identify, prevent, and mitigate medication errors.

Presenter:

Mishale Mistry, PharmD, MPH, Acting Associate Director, FDA/CDER/OSE/OMEPRM/DMEPA

There is no cost for this program.

Target audience: Physicians, Physician Assistants, Nurses, Pharmacists, Pharmacy Technicians, Students, and other health care professionals

Continuing Education Credit:

  • Physicians and Physician Assistants: The Food and Drug Administration, Center for Drug Evaluation and Research is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians and physician assistants. The Food and Drug Administration – Center for Drug Evaluation and Research designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)TM.  Physicians and physician assistants should claim only the credit commensurate with the extent of their participation in the activity.
  • Pharmacy and Pharmacy Technicians: The FDA-Center for Drug Evaluation and Research is accredited by the Accreditation Council for Pharmacy Education as a Provider of continuing pharmacy education. (ACPE Universal Activity No. 0601-0000-17-084-L04-P and ACPE Universal Activity No. 0601-0000-17-085-L04-T).  This program meets the criteria for 1 contact hour(s) of pharmacy education and pharmacy technician education.
  • Nursing: FDA, Center for Drug Evaluation and Research is an approved provider of continuing nursing education by the Maryland Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. This 1 contact hour Education Activity is provided by FDA, Center for Drug Evaluation and Research.  Each nurse should claim only the time that he/she actually spent in the educational activity.

 Please direct your comments or questions via email to DDIWebinars@fda.hhs.gov.